Browse through our press and news section by category:

26.10.2018, Shanghai/Mainz

SCHOTT AG to expand global capacity of borosilicate glass tubing with new plant in China

The company signed an investment agreement to build a pharmaceutical tubing production site in Zhejiang Province.
In light of the growing demand for high quality Type 1 pharmaceutical tubing in China, SCHOTT will significantly invest into a tubing greenfield site for the production of FIOLAX® tubing. “The new production site in Jinyun County, Zhejiang Province is a clear commitment to developing the local market,” comments Dr. Patrick Markschläger, Executive Vice President of SCHOTT AG Business Unit Tubing. “The site will feature the company’s most advanced production technology, which will strongly support the further development of the domestic pharmaceutical industry.” SCHOTT, having a track record of more than 100 years’ experience in the global pharmaceutical packaging industry, will also provide and share glass-related and regulatory know-how.

In view of the increasingly stringent regulatory framework to support patient safety standards in China, the demand for high quality drug packaging products is steadily increasing. FIOLAX® glass tubing has become the first choice of glass packaging material in the world since it was launched in 1911. Due to the excellent performance concerning chemical and physical properties, it is widely used for high-quality pharmaceutical containers such as vials, ampoules, cartridges and syringes.

SCHOTT is a leading international technology group in the areas of specialty glass and glass-ceramics. The company has more than 130 years of outstanding development, materials and technology expertise and offers a broad portfolio of high-quality products and intelligent solutions. SCHOTT is an innovative enabler for many industries, including the home appliance, pharma, electronics, optics, life sciences, automotive and aviation industries. SCHOTT strives to play an important part of everyone’s life and is committed to innovation and sustainable success. With more than 15,500 employees at production sites and sales offices in 33 countries, the group has a global presence. In the 2016/2017 fiscal year, SCHOTT generated sales of 2.05 billion euros. The parent company, SCHOTT AG, has its headquarters in Mainz (Germany) and is solely owned by the Carl Zeiss Foundation. As a foundation company, SCHOTT assumes special responsibility for its employees, society and the environment.
Press contact
SCHOTT AG
Salvatore Ruggiero
Vice President Marketing and Communication
Hattenbergstraße 10
55122 Mainz
Germany
Phone: +49 6131/66-4140
Further information
SCHOTT AG
Joana Kornblum
PR & Communication Assistant Manager
Pharma | Medical | Diagnostics
Hattenbergstraße 10
55122 Mainz
Phone: +49 6131/66-4073
SCHOTT uses Cookies on this Website to enhance the user experience and provide the best possible Service. By continuing to browse the Website, you consent to our use of Cookies.